[Ramipril treatment of heart failure in disseminated forms of pulmonary tuberculosis]
- PMID: 10420746
[Ramipril treatment of heart failure in disseminated forms of pulmonary tuberculosis]
Abstract
A total of 108 patients with heart failure-complicated disseminated pulmonary tuberculosis were followed up. Fifty eight patients received combined therapy including the angiotensin-converting enzyme inhibitor ramipril in a daily dose of 0.25-0.50 mg for 1.5-2 months. Fifty ramipril-untreated patients comprised a control group. Examinations revealed the benefits of the agent in decompensatory chronic cor pulmonale as improved right ventricular systolic and diastolic functions and health in the patients.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical